Pfizer to seek approval in fall for COVID-19 vaccine use in children aged 2 to 11

Emergency use authorization for the Pfizer COVID-19 vaccine to be given to children ages 2 to 11 years could be sought from the U.S. Food and Drug Administration by September, the company said Tuesday.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.